Managing Cognitive Dysfunction through the Continuum of Alzheimer's Disease: Role of Pharmacotherapy

Author： Delrieu Julien   Piau Antoine   Caillaud Céline   Voisin Thierry   Vellas Bruno  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.3, 2011-03, pp. : 213-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Key Role of Mitochondria in Alzheimer's Disease Synaptic Dysfunction

By  

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6440-6450

Bentham Science Publishers

Access to resources Recommend Favorite

Does insulin dysfunction play a role in Alzheimer's disease?

By Gasparini L.   Netzer W.J.   Greengard P.   Xu H.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 6, 2002-06 ,pp. : 288-293

Elsevier

Access to resources Recommend Favorite

Current perspectives on pharmacotherapy of Alzheimer's disease

By Chopra Kanwaljit   Misra Shubham   Kuhad Anurag  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 335-350

Informa Healthcare

Access to resources Recommend Favorite

Cognitive Dysfunction in Bipolar Disorder: Future Place of Pharmacotherapy

By Burdick Katherine E.   Braga Raphael J.  

CNS Drugs, Vol. 21, Iss. 12, 2007-01 ,pp. : 971-981

Adis International

Access to resources Recommend Favorite

The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 139-145

Bentham Science Publishers

Access to resources Recommend Favorite